Synonymous mutations in oncogenesis and apoptosis versus survival unveiled by network modeling
暂无分享,去创建一个
Jianwei Shuai | Hong Qi | Liyu Liu | Xiang Li | Liyu Liu | Hong Qi | Jianwei Shuai | Xiang Li | Yuan Chen | Yuan Chen
[1] Gary D Bader,et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry , 2002, Nature.
[2] Masakazu Toi,et al. Nuclear factor-κB inhibitors as sensitizers to anticancer drugs , 2005, Nature Reviews Cancer.
[3] J. M. Nicholson,et al. Is carcinogenesis a form of speciation? , 2011, Cell cycle.
[4] Nils Blüthgen,et al. Mathematical Modeling Identifies Inhibitors of Apoptosis as Mediators of Positive Feedback and Bistability , 2006, PLoS Comput. Biol..
[5] A. Barabasi,et al. An empirical framework for binary interactome mapping , 2008, Nature Methods.
[6] Lynne Pearce,et al. Breaking the silence. , 2011, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[7] B. Vogelstein,et al. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.
[8] A. Krainer,et al. Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.
[9] R. Schwartz,et al. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α , 1998 .
[10] D. Stupack. Caspase-8 as a therapeutic target in cancer. , 2013, Cancer letters.
[11] J. Plotkin,et al. Synonymous but not the same: the causes and consequences of codon bias , 2011, Nature Reviews Genetics.
[12] L. Rorke,et al. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] Stephen C. J. Parker,et al. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma , 2013, Proceedings of the National Academy of Sciences.
[14] J. Tavaré,et al. Rapid caspase‐3 activation during apoptosis revealed using fluorescence‐resonance energy transfer , 2000, EMBO reports.
[15] T. Nishiuchi,et al. Mechanism and Repertoire of ASC-Mediated Gene Expression1 , 2009, The Journal of Immunology.
[16] J. Tschopp,et al. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. , 2000, Cancer research.
[17] G. Courtois,et al. Inhibition of the NF-kappaB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-kappaB essential modulator NEMO. , 2008, Cell death and differentiation.
[18] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[19] D. Lauffenburger,et al. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. , 2008, Molecular cell.
[20] Jianfeng Pei,et al. Mutation-induced protein interaction kinetics changes affect apoptotic network dynamic properties and facilitate oncogenesis , 2015, Proceedings of the National Academy of Sciences.
[21] Hanlee P. Ji,et al. Multigene amplification and massively parallel sequencing for cancer mutation discovery , 2007, Proceedings of the National Academy of Sciences.
[22] Albert-László Barabási,et al. Scale-Free Networks: A Decade and Beyond , 2009, Science.
[23] William Stafford Noble,et al. Large-scale identification of yeast integral membrane protein interactions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] C. Kimchi-Sarfaty,et al. Understanding the contribution of synonymous mutations to human disease , 2011, Nature Reviews Genetics.
[25] A. Zernecke,et al. Inhibition of inflammatory endothelial responses by a pathway involving caspase activation and p65 cleavage. , 2001, Biochemistry.
[26] Jochen H M Prehn,et al. Systems analysis of effector caspase activation and its control by X‐linked inhibitor of apoptosis protein , 2006, The EMBO journal.
[27] G. Courtois,et al. Inhibition of the NF-κB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-κB essential modulator NEMO , 2008, Cell Death and Differentiation.
[28] C. Sonnenschein,et al. The tissue organization field theory of cancer: A testable replacement for the somatic mutation theory , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.
[29] R. Schwartz,et al. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] L. Hurst,et al. The price of silent mutations. , 2009, Scientific American.
[31] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[32] Jia Chen,et al. Correlation between Oncogenic Mutations and Parameter Sensitivity of the Apoptosis Pathway Model , 2014, PLoS Comput. Biol..
[33] L. Hurst,et al. Hearing silence: non-neutral evolution at synonymous sites in mammals , 2006, Nature Reviews Genetics.
[34] A. Baldwin,et al. Apoptosis Promotes a Caspase-induced Amino-terminal Truncation of IκBα That Functions as a Stable Inhibitor of NF-κB* , 1999, The Journal of Biological Chemistry.
[35] L. Hood,et al. Activation of the NF-κB pathway by Caspase 8 and its homologs , 2000, Oncogene.
[36] J. Schafer,et al. Missing data: our view of the state of the art. , 2002, Psychological methods.
[37] R. Ravi,et al. CD95 (Fas)-induced Caspase-mediated Proteolysis of NF-κB , 1998 .
[38] Gary D Bader,et al. The human genome and drug discovery after a decade. Roads (still) not taken , 2011, 1102.0448.
[39] Lippincott-Schwartz,et al. Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .
[40] Grant W. Brown,et al. Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map , 2007, Nature.
[41] Chava Kimchi-Sarfaty,et al. Exposing synonymous mutations. , 2014, Trends in genetics : TIG.
[42] M. Lenardo,et al. Caspase-8 Regulation by Direct Interaction with TRAF6 in T Cell Receptor-Induced NF-κB Activation , 2006, Current Biology.
[43] E. Kandel,et al. MicroRNA analysis suggests an additional level of feedback regulation in the NF-κB signaling cascade , 2015, Oncotarget.
[44] L. Ouyang,et al. Systems biology network-based discovery of a small molecule activator BL-AD008 targeting AMPK/ZIPK and inducing apoptosis in cervical cancer , 2015, Oncotarget.
[45] Markus Rehm,et al. Single-cell Fluorescence Resonance Energy Transfer Analysis Demonstrates That Caspase Activation during Apoptosis Is a Rapid Process , 2002, The Journal of Biological Chemistry.
[46] A. Kieser,et al. The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL , 2012, Cell Death and Disease.
[47] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[48] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[49] B. Zhivotovsky,et al. Caspases and cancer , 2011, Cell Death and Differentiation.
[50] N. Perkins,et al. The diverse and complex roles of NF-κB subunits in cancer , 2012, Nature Reviews Cancer.
[51] H. Curtis. Formal discussion of: somatic mutations and carcinogenesis. , 1965, Cancer research.
[52] J C Reed,et al. Pro-caspase-3 Is a Major Physiologic Target of Caspase-8* , 1998, The Journal of Biological Chemistry.
[53] P. Scheurich,et al. Tumor necrosis factor signaling , 2003, Cell Death and Differentiation.
[54] Michael Karin,et al. NF-kappaB at the crossroads of life and death. , 2002, Nature immunology.
[55] A. Hoffmann,et al. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.
[56] P. Chaudhary,et al. An Evolutionary Conserved Pathway of Nuclear Factor-κB Activation Involving Caspase-mediated Cleavage and N-end Rule Pathway-mediated Degradation of IκBα* , 2004, Journal of Biological Chemistry.
[57] R. Kassen,et al. Adaptive synonymous mutations in an experimentally evolved Pseudomonas fluorescens population , 2014, Nature Communications.
[58] J. Valcárcel,et al. Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers , 2014, Cell.
[59] Frank Allgöwer,et al. Heterogeneity reduces sensitivity of cell death for TNF-Stimuli , 2011, BMC Systems Biology.
[60] S. Akira,et al. Cutting Edge: Roles of Caspase-8 and Caspase-10 in Innate Immune Responses to Double-Stranded RNA , 2006, The Journal of Immunology.
[61] Y. Lin,et al. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. , 1999, Genes & development.
[62] Ben Lehner,et al. Tissue specificity and the human protein interaction network , 2009, Molecular systems biology.
[63] Edward C Stites,et al. Network Analysis of Oncogenic Ras Activation in Cancer , 2007, Science.
[64] A. Knudson,et al. Two genetic hits (more or less) to cancer , 2001, Nature Reviews Cancer.
[65] M. Toi,et al. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. , 2005, Nature reviews. Cancer.
[66] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[67] A. Butte,et al. Non-Synonymous and Synonymous Coding SNPs Show Similar Likelihood and Effect Size of Human Disease Association , 2010, PloS one.
[68] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[69] J. Bertin,et al. Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death , 2014, Proceedings of the National Academy of Sciences.
[70] L. Hood,et al. Activation of the NF-kappaB pathway by caspase 8 and its homologs. , 2000, Oncogene.
[71] R. Ozawa,et al. A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[72] R. Schreiber,et al. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.
[73] Sean R. Collins,et al. Global landscape of protein complexes in the yeast Saccharomyces cerevisiae , 2006, Nature.
[74] F. Behm,et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN , 2000, Nature Medicine.
[75] P. Ao,et al. Endogenous molecular network reveals two mechanisms of heterogeneity within gastric cancer , 2015, Oncotarget.
[76] Bernhard O Palsson,et al. The convex basis of the left null space of the stoichiometric matrix leads to the definition of metabolically meaningful pools. , 2003, Biophysical journal.
[77] David Tollervey,et al. Coding-Sequence Determinants of Gene Expression in Escherichia coli , 2009, Science.
[78] M. Peter,et al. The TNF Receptor 1 A Split Personality Complex , 2003, Cell.
[79] K. Shokat,et al. Human Catechol-O-Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary Structure , 2006, Science.
[80] M. Boutros,et al. Clustering phenotype populations by genome-wide RNAi and multiparametric imaging , 2010, Molecular systems biology.
[81] Zhilin Qu,et al. Regulation of the mammalian cell cycle: a model of the G1-to-S transition. , 2003, American journal of physiology. Cell physiology.
[82] T. Pawson,et al. Assembly of Cell Regulatory Systems Through Protein Interaction Domains , 2003, Science.
[83] Roland Eils,et al. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells , 2010, Molecular systems biology.
[84] L. Hood,et al. Cancer as robust intrinsic state of endogenous molecular-cellular network shaped by evolution. , 2008, Medical hypotheses.
[85] Benjamin J. Raphael,et al. Mutational landscape and significance across 12 major cancer types , 2013, Nature.
[86] R. Ravi,et al. CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB. , 1998, Cancer research.
[87] James R. Knight,et al. A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae , 2000, Nature.
[88] Yanhui Hu,et al. Integrating protein-protein interaction networks with phenotypes reveals signs of interactions , 2013, Nature Methods.
[89] M. Stratton,et al. The cancer genome , 2009, Nature.
[90] H. Horvitz,et al. Phosphorylation of IκB-α Inhibits Its Cleavage by Caspase CPP32 in Vitro * , 1997, The Journal of Biological Chemistry.
[91] E. Solary,et al. Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. , 2007, Blood.
[92] J. Tschopp,et al. Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.
[93] J C Reed,et al. A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases* , 1998, The Journal of Biological Chemistry.
[94] T. Seyfried,et al. Cancer as a metabolic disease: implications for novel therapeutics , 2013, Carcinogenesis.
[95] M. Kim,et al. Caspase-3-mediated Cleavage of the NF-κB Subunit p65 at the NH2 Terminus Potentiates Naphthoquinone Analog-induced Apoptosis* , 2001, The Journal of Biological Chemistry.
[96] H. Horvitz,et al. Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro. , 1997, The Journal of biological chemistry.